News

New 190,000ft² facility built to LEED-Gold certified standards, is expected to accommodate 500 employees initially. Biogen Idec chief executive officer George Scangos said the new facility will unite

To make the EMR transition easier, Practice Fusion will also connect with Meridian Health’s laboratories. Meridian Health information technology senior vice president Rebecca Weber said the company is

The new entity will research, develop, manufacture and market new medicines and nutritional products derived from botanical plant origins globally, with focus on gastrointestinal indications and may also

ACG Associated Capsules president and CEO S M J Noronha was quoted by Express Pharma as saying that the construction work of the phase I is almost ready.

The $100m facility, which will be operated by the company’s subsidiary TOT Biopharm, will produce anti-cancer drug injections. In addition, the company’s other new facility producing anti-cancer injections,

Curis president and chief executive officer Dan Passeri said the GDC-0917 agreement adds depth to current pipeline of proprietary targeted anti-cancer agents and further solidifies the company’s relationship

Under the deal, CoreRx will integrate its expertise in problem-solving and formulation/processing of small molecules with Viropro’s specialization in the development and manufacturing of biopharmaceutical drugs to provide

According to the development and commercialization deal signed between the firms, NDA acceptance by the FDA has triggered a milestone payment worth $15m to AVEO from Astellas. The

Evotec will support the pre-clinical and clinical development of glutaminyl cyclase (QC) inhibitors by running and validating its existing as well as developing biological assays. Evotec chief operating